Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Derlin, T"" wg kryterium: Wszystkie pola


Tytuł:
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study
Autorzy:
Schmidt-Hegemann, N.-S.
Kroeze, S.G.C.
Henkenberens, C.
Vogel, M.M.E.Aff4, Aff5
Kirste, S.
Becker, J.
Burger, I. A.
Derlin, T.
Bartenstein, P.
Eiber, M.
Mix, M.
la Fougère, Ch.Aff13, Aff14, Aff15
Müller, A.C.
Grosu, A.L.Aff6, Aff16
Combs, S.E.Aff4, Aff5, Aff17
Christiansen, H.
Guckenberger, M.
Belka, C.Aff1, Aff17
Pokaż więcej
Źródło:
European Journal of Nuclear Medicine and Molecular Imaging. 47(8):1852-1863
Czasopismo naukowe
Tytuł:
Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy.
Autorzy:
Widjaja L; Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. .
Werner RA; Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Krischke E; Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Christiansen H; Department of Radiation Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Bengel FM; Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Bogdanova N; Department of Radiation Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Derlin T; Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jan; Vol. 50 (2), pp. 602-612. Date of Electronic Publication: 2022 Sep 22.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms, Castration-Resistant*/diagnostic imaging
Prostatic Neoplasms, Castration-Resistant*/radiotherapy
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Male ; Humans ; Prospective Studies ; Radiopharmaceuticals/therapeutic use ; Dipeptides/therapeutic use ; Treatment Outcome ; Heterocyclic Compounds, 1-Ring/therapeutic use ; Lutetium/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Interplay between driveline infection, vessel wall inflammation, cerebrovascular events and mortality in patients with left ventricular assist device.
Autorzy:
Hupe J; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Worthmann H; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Ravenberg KK; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Grosse GM; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Ernst J; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Haverich A; Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Bengel FM; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Weissenborn K; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Schmitto JD; Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Hanke JS; Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Derlin T; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Gabriel MM; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 29; Vol. 13 (1), pp. 18552. Date of Electronic Publication: 2023 Oct 29.
Typ publikacji:
Journal Article
MeSH Terms:
Heart-Assist Devices*/adverse effects
Prosthesis-Related Infections*/etiology
Heart Failure*/complications
Humans ; Positron Emission Tomography Computed Tomography ; Fluorodeoxyglucose F18 ; Inflammation/etiology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Comparison of pretherapeutic osseous tumor volume and standard hematology for prediction of hematotoxicity after PSMA-targeted radioligand therapy.
Autorzy:
Widjaja L; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Werner RA; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Ross TL; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Bengel FM; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Derlin T; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany. derlin..
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Nov; Vol. 48 (12), pp. 4077-4088. Date of Electronic Publication: 2021 May 27.
Typ publikacji:
Journal Article
MeSH Terms:
Hematology*
Prostatic Neoplasms, Castration-Resistant*/radiotherapy
Dipeptides ; Heterocyclic Compounds, 1-Ring ; Humans ; Male ; Positron Emission Tomography Computed Tomography ; Retrospective Studies ; Treatment Outcome ; Tumor Burden
Czasopismo naukowe
Tytuł:
Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma: A PET/CT pilot study using [F]fluorodeoxyglucose
Autorzy:
Apostolova, I.
Hofheinz, F.
Buchert, R.
Steffen, I.G.
Michel, R.
Rosner, C.
Prasad, V.
Köhler, C.
Derlin, T.
Brenner, W.
Marnitz, S.
Pokaż więcej
Alternatywny tytuł:
Kombinierte Messung von Tumorperfusion und Glukosemetabolismus zur verbesserten Charakterisierung fortgeschrittener Zervixkarzinome: Eine PET/CT-Pilotstudie mit [F]Fluorodesoxyglukose
Źródło:
Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. June 2014 190(6):575-581
Czasopismo naukowe
Tytuł:
The Prognostic Value of Liquid Biopsies for Benefit of Salvage Radiotherapy in Relapsed Oligometastatic Prostate Cancer.
Autorzy:
Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Radmanesh H; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Ramachandran D; Gynecology Research Unit, Clinics of Obstetrics and Gynaecology, Hannover Medical School, 30625 Hannover, Germany.
Knoechelmann AC; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Christiansen H; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Derlin T; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
von Klot CAJ; Clinic for Urology, Hannover Medical School, 30625 Hannover, Germany.
Merten R; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Henkenberens C; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Aug 24; Vol. 14 (17). Date of Electronic Publication: 2022 Aug 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with F-DCFPyL.
Autorzy:
Werner RA; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Center University Hospital Würzburg, Würzburg, Germany.
Habacha B; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
Lütje S; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
Bundschuh L; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
Higuchi T; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Center University Hospital Würzburg, Würzburg, Germany.; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Hartrampf P; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Serfling SE; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Derlin T; Medical School Hannover, Department of Nuclear Medicine, Hannover, Germany.
Lapa C; Nuclear Medicine, Medical Faculty, University of Augsburg, Germany.
Buck AK; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Essler M; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
Pienta KJ; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eisenberger MA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Markowski MC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Shinehouse L; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
AbdAllah R; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Salavati A; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Lodge MA; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pomper MG; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gorin MA; Urology Associates and UPMC Western Maryland, Cumberland, MD, USA.; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Bundschuh RA; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
Rowe SP; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Molecular imaging [Mol Imaging] 2022 Feb 23; Vol. 2022, pp. 7056983. Date of Electronic Publication: 2022 Feb 23 (Print Publication: 2022).
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Humans ; Male ; Prospective Studies ; Tumor Burden
Czasopismo naukowe
Tytuł:
Deepening of response to prostate-specific membrane antigen ligand-targeted radioligand therapy beyond end of treatment.
Autorzy:
Derlin T; Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. Derlin..
Krischke E; Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Ross TL; Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Bengel FM; Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Sep; Vol. 48 (10), pp. 3343-3344. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate*
Humans ; Ligands ; Male
Czasopismo naukowe
Tytuł:
Vessel Wall Inflammatory Activity as Determined by F-18 Fluorodeoxyglucose PET in Large Vessel Vasculitis Is Attenuated by Immunomodulatory Drugs.
Autorzy:
Sherzay R; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Witte T; Department of Rheumatology and Immunology, Hannover Medical School, 30625 Hannover, Germany.
Derlin T; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Hoepfner M; Department of Rheumatology and Immunology, Hannover Medical School, 30625 Hannover, Germany.
Bengel FM; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2021 Jun 22; Vol. 11 (7). Date of Electronic Publication: 2021 Jun 22.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
PSMA Expression Predicts Early Biochemical Response in Patients with Metastatic Castration-Resistant Prostate Cancer under Lu-PSMA-617 Radioligand Therapy.
Autorzy:
Widjaja L; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Werner RA; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Ross TL; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Bengel FM; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Derlin T; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jun 11; Vol. 13 (12). Date of Electronic Publication: 2021 Jun 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors.
Autorzy:
Derlin T; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Bogdanova N; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Ohlendorf F; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Ramachandran D; Department of Radiation Oncology, and Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
Werner RA; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Ross TL; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Christiansen H; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Bengel FM; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Henkenberens C; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Mar 25; Vol. 13 (7). Date of Electronic Publication: 2021 Mar 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients with Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide Therapy.
Autorzy:
Ohlendorf F; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Werner RA; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Henkenberens C; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Ross TL; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Christiansen H; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
Bengel FM; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Derlin T; Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2021 Mar 12; Vol. 11 (3). Date of Electronic Publication: 2021 Mar 12.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies